Literature DB >> 22199092

Optimization of a goal maintenance task for use in clinical applications.

Dori Henderson1, Andrew B Poppe, Deanna M Barch, Cameron S Carter, James M Gold, John D Ragland, Steven M Silverstein, Milton E Strauss, Angus W MacDonald.   

Abstract

BACKGROUND: We sought to develop a Dot Pattern Expectancy task (DPX) to assess goal maintenance for use in clinical trials. Altering the standard task created 5 versions of the DPX to compare-a standard version and 4 others. Alterations in the interstimulus interval (ISI) length and the strength of a learned prepotent response distinguished the different tasks. These adjustments were designed to decrease administration time and/or improve reliability of the data.
METHODS: We determined participant eligibility in an initial session (the first of 3) using clinical interviewing tools. The initial session also included a demographic assessment and assessments of community functioning and symptom severity. All versions of the DPX were administered, across 3 sessions. Specific deficits on the context processing compared with difficulty control condition were evaluated using mixed-effects logistic regression within a hierarchical linear model.
RESULTS: We analyzed the data from 136 control participants and 138 participants with schizophrenia. Relative to a difficulty control condition, patients performed worse than controls on context processing conditions that required goal maintenance. ISI did not predict errors. Stronger prepotency was associated with increased errors in the difficulty control relative to context processing condition for controls, which improved the interpretability of findings for patients. Reliability was acceptable for a version of the task with a 10-minute running time.
CONCLUSIONS: The best compromise between task duration and interpretability occurred on a version with a short ISI and a strong prepotency.

Entities:  

Mesh:

Year:  2012        PMID: 22199092      PMCID: PMC3245586          DOI: 10.1093/schbul/sbr172

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  21 in total

Review 1.  Performance-based measures of functional skills: usefulness in clinical treatment studies.

Authors:  Philip D Harvey; Dawn I Velligan; Alan S Bellack
Journal:  Schizophr Bull       Date:  2007-05-09       Impact factor: 9.306

2.  The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity.

Authors:  Keith H Nuechterlein; Michael F Green; Robert S Kern; Lyle E Baade; Deanna M Barch; Jonathan D Cohen; Susan Essock; Wayne S Fenton; Frederick J Frese; James M Gold; Terry Goldberg; Robert K Heaton; Richard S E Keefe; Helena Kraemer; Raquelle Mesholam-Gately; Larry J Seidman; Ellen Stover; Daniel R Weinberger; Alexander S Young; Steven Zalcman; Stephen R Marder
Journal:  Am J Psychiatry       Date:  2008-01-02       Impact factor: 18.112

Review 3.  CNTRICS final task selection: working memory.

Authors:  Deanna M Barch; Marc G Berman; Randy Engle; Jessica Hurdelbrink Jones; John Jonides; Angus Macdonald; Derek Evan Nee; Thomas S Redick; Scott R Sponheim
Journal:  Schizophr Bull       Date:  2008-11-05       Impact factor: 9.306

Review 4.  Building a clinically relevant cognitive task: case study of the AX paradigm.

Authors:  Angus W MacDonald
Journal:  Schizophr Bull       Date:  2008-05-16       Impact factor: 9.306

5.  Context-processing deficits in schizophrenia: converging evidence from three theoretically motivated cognitive tasks.

Authors:  J D Cohen; D M Barch; C Carter; D Servan-Schreiber
Journal:  J Abnorm Psychol       Date:  1999-02

6.  Schizophrenic deficits in the processing of context. A test of a theoretical model.

Authors:  D Servan-Schreiber; J D Cohen; S Steingard
Journal:  Arch Gen Psychiatry       Date:  1996-12

Review 7.  Context, cortex, and dopamine: a connectionist approach to behavior and biology in schizophrenia.

Authors:  J D Cohen; D Servan-Schreiber
Journal:  Psychol Rev       Date:  1992-01       Impact factor: 8.934

8.  Measurement issues in the use of cognitive neuroscience tasks in drug development for impaired cognition in schizophrenia: a report of the second consensus building conference of the CNTRICS initiative.

Authors:  Deanna M Barch; Cameron S Carter
Journal:  Schizophr Bull       Date:  2008-05-21       Impact factor: 9.306

9.  Identifying cognitive mechanisms targeted for treatment development in schizophrenia: an overview of the first meeting of the Cognitive Neuroscience Treatment Research to Improve Cognition in Schizophrenia Initiative.

Authors:  Cameron S Carter; Deanna M Barch; Robert W Buchanan; Ed Bullmore; John H Krystal; Jonathan Cohen; Mark Geyer; Michael Green; Keith H Nuechterlein; Trevor Robbins; Steven Silverstein; Edward E Smith; Milton Strauss; Til Wykes; Robert Heinssen
Journal:  Biol Psychiatry       Date:  2008-05-07       Impact factor: 13.382

Review 10.  Cognitive neuroscience-based approaches to measuring and improving treatment effects on cognition in schizophrenia: the CNTRICS initiative.

Authors:  Cameron S Carter; Deanna M Barch
Journal:  Schizophr Bull       Date:  2007-07-14       Impact factor: 9.306

View more
  45 in total

1.  Cognitive neuroscience test reliability and clinical applications for schizophrenia.

Authors:  James Gold
Journal:  Schizophr Bull       Date:  2012-01       Impact factor: 9.306

2.  The clinical translation of a measure of gain control: the contrast-contrast effect task.

Authors:  Deanna M Barch; Cameron S Carter; Steve C Dakin; James Gold; Steven J Luck; Angus Macdonald; John D Ragland; Steven Silverstein; Milton E Strauss
Journal:  Schizophr Bull       Date:  2011-11-17       Impact factor: 9.306

3.  Explicit and implicit reinforcement learning across the psychosis spectrum.

Authors:  Deanna M Barch; Cameron S Carter; James M Gold; Sheri L Johnson; Ann M Kring; Angus W MacDonald; Diego A Pizzagalli; J Daniel Ragland; Steven M Silverstein; Milton E Strauss
Journal:  J Abnorm Psychol       Date:  2017-04-13

4.  Impaired context processing as a potential marker of psychosis risk state.

Authors:  Tara A Niendam; Tyler A Lesh; Jong Yoon; Andrew J Westphal; Natalie Hutchison; J Daniel Ragland; Marjorie Solomon; Michael Minzenberg; Cameron S Carter
Journal:  Psychiatry Res       Date:  2013-10-11       Impact factor: 3.222

5.  Fronto-parietal and cingulo-opercular network integrity and cognition in health and schizophrenia.

Authors:  Julia M Sheffield; Grega Repovs; Michael P Harms; Cameron S Carter; James M Gold; Angus W MacDonald; J Daniel Ragland; Steven M Silverstein; Douglass Godwin; Deanna M Barch
Journal:  Neuropsychologia       Date:  2015-05-13       Impact factor: 3.139

6.  Immediate versus delayed control demands elicit distinct mechanisms for instantiating proactive control.

Authors:  Jacqueline R Janowich; James F Cavanagh
Journal:  Cogn Affect Behav Neurosci       Date:  2019-08       Impact factor: 3.282

7.  Multivariate Relationships Between Cognition and Brain Anatomy Across the Psychosis Spectrum.

Authors:  Amanda L Rodrigue; Jennifer E McDowell; Neeraj Tandon; Matcheri S Keshavan; Carol A Tamminga; Godfrey D Pearlson; John A Sweeney; Robert D Gibbons; Brett A Clementz
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2018-03-31

8.  Emotion regulation abnormalities in schizophrenia: Directed attention strategies fail to decrease the neurophysiological response to unpleasant stimuli.

Authors:  Gregory P Strauss; Emily S Kappenman; Adam J Culbreth; Lauren T Catalano; Kathryn L Ossenfort; Bern G Lee; James M Gold
Journal:  J Abnorm Psychol       Date:  2014-12-08

9.  Cognition in schizophrenia and schizo-affective disorder: impairments that are more similar than different.

Authors:  A Owoso; C S Carter; J M Gold; A W MacDonald; J D Ragland; S M Silverstein; M E Strauss; D M Barch
Journal:  Psychol Med       Date:  2013-03-25       Impact factor: 7.723

Review 10.  Generalized and specific neurocognitive deficits in psychotic disorders: utility for evaluating pharmacological treatment effects and as intermediate phenotypes for gene discovery.

Authors:  James L Reilly; John A Sweeney
Journal:  Schizophr Bull       Date:  2014-02-26       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.